— Know what they know.
Not Investment Advice

MRVI NASDAQ

Maravai LifeSciences Holdings, Inc.
1W: +4.4% 1M: +21.4% 3M: +44.5% YTD: +31.8% 1Y: +86.7% 3Y: -66.5% 5Y: -88.2%
$4.40
-0.08 (-1.79%)
 
Weekly Expected Move ±13.9%
$3 $4 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 68 · $1.2B mcap · 103M float · 2.04% daily turnover · Short 29% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
37.8 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 114.2%  ·  5Y Avg: 22.7%
Cost Advantage ★
54
Intangibles
22
Switching Cost
38
Network Effect
33
Scale
47
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MRVI has No discernible competitive edge (37.8/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 114.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$6
Low
$6
Avg Target
$6
High
Based on 1 analyst since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 7Hold: 6Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$6.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-08 Deutsche Bank $25 $6 -19 +33.5% $4.50
2025-12-15 Wells Fargo Brandon Couillard Initiated $4 +24.8% $3.60
2025-03-21 Stifel Nicolaus Initiated $5 +120.3% $2.27
2024-05-09 Robert W. Baird Catherine Schulte Initiated $10 +12.7% $8.87
2022-12-14 Deutsche Bank Initiated $25 +66.3% $15.03
2022-12-06 RBC Capital Initiated $22 +76.0% $12.50

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
2
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MRVI receives an overall rating of C. Areas of concern: ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-11 C- C
2026-05-08 C C-
2026-04-21 C+ C
2026-02-26 C C+
2026-01-03 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

25 Grade D
Profitability
18
Balance Sheet
48
Earnings Quality
55
Growth
55
Value
31
Momentum
56
Safety
15
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. MRVI scores highest in Momentum (56/100) and lowest in Safety (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.62
Distress Zone
Piotroski F-Score
3/9
Beneish M-Score
-3.08
Unlikely Manipulator
Ohlson O-Score
-6.31
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BB-
Score: 37.1/100
Trend: Improving
Earnings Quality
OCF/NI: 0.38x
Accruals: -7.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MRVI scores 0.62, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MRVI scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MRVI's score of -3.08 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MRVI's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MRVI receives an estimated rating of BB- (score: 37.1/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-6.16x
PEG
-0.26x
P/S
5.94x
P/B
3.05x
P/FCF
-7.99x
P/OCF
EV/EBITDA
-2.32x
EV/Revenue
1.14x
EV/EBIT
-1.46x
EV/FCF
-4.49x
Earnings Yield
-25.23%
FCF Yield
-12.52%
Shareholder Yield
0.03%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. MRVI currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.554
NI / EBT
×
Interest Burden
1.183
EBT / EBIT
×
EBIT Margin
-0.780
EBIT / Rev
×
Asset Turnover
0.230
Rev / Assets
×
Equity Multiplier
3.308
Assets / Equity
=
ROE
-38.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MRVI's ROE of -38.9% is driven by financial leverage (equity multiplier: 3.31x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 0.55 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1381 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.40
Median 1Y
$2.38
5th Pctile
$0.67
95th Pctile
$8.46
Ann. Volatility
72.9%
Analyst Target
$6.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Bernd Brust
Chief Executive Officer
$388,863 $7,660,000 $10,129,708
William E. Martin
III Former Chief Executive Officer
$345,000 $2,603,552 $3,845,263
Raj Asarpota Financial
ancial Officer
$253,366 $2,172,500 $3,506,793
Peter Leddy, PhD
Chief Administrative Officer
$372,200 $1,041,422 $1,849,804
Kevin Herde Financial
ief Financial Officer
$247,771 $1,041,422 $1,730,738
Kurt Oreshack Counsel
ry and General Counsel
$455,442 $781,065 $1,470,977
Christine Dolan Manager,
e Vice President and General Manager, Cygnus
$450,966 $650,889 $1,454,198

CEO Pay Ratio

26:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,129,708
Avg Employee Cost (SGA/emp): $394,184
Employees: 435

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
435
-23.7% YoY
Revenue / Employee
$426,995
Rev: $185,743,000
Profit / Employee
$-300,628
NI: $-130,773,000
SGA / Employee
$394,184
Avg labor cost proxy
R&D / Employee
$53,628
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 96.5% 1.6% 89.9% 1.1% 1.2% 1.2% 51.2% 35.6% 17.5% 5.7% -24.7% -27.2% -27.5% -46.7% -39.0% -43.9% -52.5% -32.7% -48.6% -38.9% -38.89%
ROA 6.7% 11.0% 11.4% 14.1% 15.5% 14.9% 10.5% 7.3% 3.6% 1.2% -6.3% -7.0% -7.0% -11.9% -11.6% -13.0% -15.6% -9.7% -14.7% -11.8% -11.76%
ROIC 55.9% 86.6% 1.4% 1.6% 1.7% 1.6% 1.0% 74.0% 39.5% 17.5% 1.6% 3.1% 3.1% 33.1% -49.0% -55.3% -67.2% -7.9% -17.1% 1.1% 1.14%
ROCE 24.1% 38.0% 30.6% 34.5% 35.9% 33.7% 26.3% 18.9% 10.3% 4.5% 47.4% 46.1% 46.2% 35.2% -22.5% -26.1% -32.6% -19.6% -28.7% -22.0% -21.99%
Gross Margin 82.6% 84.3% 82.2% 83.6% 84.6% 80.0% 74.0% 57.4% 37.2% 45.1% 52.6% 40.3% 47.9% 43.5% 33.6% 16.5% 16.4% 13.6% 24.5% 51.2% 51.19%
Operating Margin 70.5% 75.9% 66.1% 68.5% 74.4% 61.1% 53.4% 3.2% -16.9% -23.1% -9.6% -29.4% -13.0% -2.6% -67.6% -1.0% -1.4% 2.8% -13.5% 3.8% 3.76%
Net Margin 22.6% 26.3% 24.3% 27.4% 29.3% 23.3% 18.4% -0.1% -9.5% -9.7% -1.4% -18.8% -10.3% -1.5% -46.4% -63.9% -83.5% -61.4% -71.6% -5.7% -5.67%
EBITDA Margin 75.2% 81.4% 66.4% 73.2% 77.6% 66.3% 56.7% 23.1% 7.9% 6.2% 9.2% 3.4% 13.0% -2.3% -36.7% -66.2% -1.1% -54.0% -83.7% 23.5% 23.47%
FCF Margin 57.5% 55.5% 44.2% 53.4% 52.0% 52.7% 58.8% 60.8% 49.3% 38.8% 21.0% -11.2% -6.1% -4.2% -8.9% -9.8% -20.7% -34.5% -38.1% -25.3% -25.34%
OCF Margin 61.1% 58.2% 46.0% 54.9% 53.3% 54.6% 60.7% 63.9% 57.7% 51.9% 43.7% 11.9% 11.1% 10.8% 2.9% 2.7% -9.8% -25.7% -31.0% -19.3% -19.30%
ROE 3Y Avg snapshot only -43.57%
ROE 5Y Avg snapshot only -6.23%
ROA 3Y Avg snapshot only -12.84%
ROIC 3Y Avg snapshot only 24.86%
ROIC Economic snapshot only 14.54%
Cash ROA snapshot only -5.13%
Cash ROIC snapshot only -1.27%
CROIC snapshot only -1.67%
NOPAT Margin snapshot only 17.32%
Pretax Margin snapshot only -92.22%
R&D / Revenue snapshot only 10.91%
SGA / Revenue snapshot only 77.78%
SBC / Revenue snapshot only 7.74%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 54.88 42.96 28.13 19.08 14.00 14.12 8.56 12.04 21.71 53.71 -7.27 -8.76 -7.36 -5.24 -5.26 -1.95 -1.79 -3.43 -3.61 -3.96 -6.162
P/S Ratio 10.09 8.95 6.39 4.80 3.77 3.71 2.13 2.57 3.01 3.14 3.00 4.19 3.49 4.25 2.94 1.31 1.61 2.16 2.54 2.02 5.936
P/B Ratio 52.94 67.63 16.20 13.63 10.98 10.65 3.46 3.39 3.01 2.42 2.08 2.75 2.33 2.82 2.34 0.97 1.07 1.28 2.22 1.95 3.045
P/FCF 17.55 16.13 14.47 9.01 7.24 7.03 3.63 4.23 6.11 8.10 14.27 -37.41 -57.48 -100.41 -32.83 -13.38 -7.78 -6.26 -6.67 -7.99 -7.989
P/OCF 16.52 15.38 13.89 8.74 7.07 6.79 3.51 4.02 5.23 6.06 6.86 35.10 31.45 39.35 102.01 48.45
EV/EBITDA 16.99 13.68 8.77 6.55 5.09 5.24 3.01 4.00 5.97 8.84 1.27 1.70 1.44 2.21 -5.20 -1.95 -1.60 -3.72 -1.97 -2.32 -2.316
EV/Revenue 10.85 9.48 6.42 4.83 3.79 3.73 2.08 2.51 2.93 3.03 3.12 4.32 3.62 4.38 3.15 1.54 1.86 2.44 1.56 1.14 1.138
EV/EBIT 18.38 14.64 9.21 6.87 5.32 5.51 3.21 4.39 7.11 12.97 1.36 1.84 1.56 2.46 -3.82 -1.50 -1.29 -2.51 -1.40 -1.46 -1.460
EV/FCF 18.88 17.08 14.54 9.06 7.29 7.08 3.54 4.12 5.94 7.82 14.86 -38.59 -59.61 -103.49 -35.18 -15.67 -8.99 -7.08 -4.10 -4.49 -4.494
Earnings Yield 1.8% 2.3% 3.6% 5.2% 7.1% 7.1% 11.7% 8.3% 4.6% 1.9% -13.8% -11.4% -13.6% -19.1% -19.0% -51.3% -56.0% -29.2% -27.7% -25.2% -25.23%
FCF Yield 5.7% 6.2% 6.9% 11.1% 13.8% 14.2% 27.5% 23.7% 16.4% 12.3% 7.0% -2.7% -1.7% -1.0% -3.0% -7.5% -12.9% -16.0% -15.0% -12.5% -12.52%
EV/Gross Profit snapshot only 3.926
Acquirers Multiple snapshot only 5.191
Shareholder Yield snapshot only 0.03%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.54 2.54 7.89 7.89 7.89 7.89 7.70 7.70 7.70 7.70 8.00 8.00 8.00 8.00 7.53 7.53 7.53 7.53 6.60 6.60 6.596
Quick Ratio 2.28 2.28 7.34 7.34 7.34 7.34 7.31 7.31 7.31 7.31 7.41 7.41 7.41 7.41 6.65 6.65 6.65 6.65 5.69 5.69 5.694
Debt/Equity 6.67 6.67 1.82 1.82 1.82 1.82 1.07 1.07 1.07 1.07 1.47 1.47 1.47 1.47 1.16 1.16 1.16 1.16 0.17 0.17 0.168
Net Debt/Equity 4.01 4.01 0.08 0.08 0.08 0.08 -0.09 -0.09 -0.09 -0.09 0.09 0.09 0.09 0.09 0.17 0.17 0.17 0.17 -0.85 -0.85 -0.854
Debt/Assets 0.46 0.46 0.30 0.30 0.30 0.30 0.26 0.26 0.26 0.26 0.41 0.41 0.41 0.41 0.37 0.37 0.37 0.37 0.05 0.05 0.046
Debt/EBITDA 1.99 1.28 0.98 0.87 0.84 0.89 0.96 1.30 2.20 4.07 0.86 0.88 0.87 1.11 -2.40 -1.98 -1.50 -2.99 -0.24 -0.35 -0.353
Net Debt/EBITDA 1.20 0.77 0.04 0.04 0.03 0.04 -0.08 -0.10 -0.18 -0.33 0.05 0.05 0.05 0.07 -0.35 -0.29 -0.22 -0.43 1.23 1.80 1.801
Interest Coverage 11.26 13.51 20.15 28.09 34.13 41.87 28.01 13.85 6.96 2.41 14.46 14.35 12.96 9.51 -4.48 -5.69 -8.07 -5.89 -7.71 -6.15 -6.147
Equity Multiplier 14.36 14.36 6.08 6.08 6.08 6.08 4.19 4.19 4.19 4.19 3.57 3.57 3.57 3.57 3.10 3.10 3.10 3.10 3.63 3.63 3.628
Cash Ratio snapshot only 4.829
Debt Service Coverage snapshot only -3.877
Cash to Debt snapshot only 6.096
FCF to Debt snapshot only -1.458
Defensive Interval snapshot only 6115.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.37 0.53 0.50 0.56 0.58 0.57 0.42 0.34 0.26 0.20 0.15 0.15 0.15 0.15 0.21 0.19 0.17 0.15 0.21 0.23 0.230
Inventory Turnover 2.78 3.75 3.35 3.55 3.54 3.68 3.57 3.43 3.56 3.52 3.15 3.24 3.14 3.14 2.97 2.99 3.02 3.00 3.36 3.21 3.210
Receivables Turnover 9.10 13.12 9.48 10.63 10.92 10.76 6.89 5.60 4.25 3.28 2.99 2.84 2.88 2.87 5.57 5.19 4.64 4.13 5.80 6.40 6.396
Payables Turnover 31.02 41.82 25.51 27.06 27.00 28.07 23.89 22.99 23.81 23.60 17.79 18.35 17.75 17.77 13.30 13.37 13.49 13.42 25.48 24.31 24.314
DSO 40 28 38 34 33 34 53 65 86 111 122 129 127 127 66 70 79 88 63 57 57.1 days
DIO 131 97 109 103 103 99 102 106 103 104 116 112 116 116 123 122 121 122 109 114 113.7 days
DPO 12 9 14 13 14 13 15 16 15 15 21 20 21 21 27 27 27 27 14 15 15.0 days
Cash Conversion Cycle 160 116 133 124 123 120 140 156 173 200 218 221 222 223 161 165 173 183 157 156 155.8 days
Fixed Asset Turnover snapshot only 168.363
Operating Cycle snapshot only 170.8 days
Cash Velocity snapshot only 0.944
Capital Intensity snapshot only 3.764
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 7.1% 2.6% 98.2% 35.5% 10.5% -19.8% -40.9% -53.7% -67.3% -61.8% -48.8% -34.0% -10.3% -11.8% -22.5% -30.6% -28.3% -15.4% -15.35%
Net Income 12.8% 5.2% 1.9% 70.8% 21.2% -32.0% -69.5% -89.7% -1.5% -1.9% -2.7% -10.1% -21.7% -24.2% -47.4% 46.0% 9.7% 35.7% 35.74%
EPS 12.0% 3.9% 1.7% 58.3% 12.3% -37.0% -71.8% -89.7% -1.5% -1.9% -2.7% -9.5% -15.1% -14.6% -38.8% 47.2% 13.0% 37.1% 37.06%
FCF 4.0% 3.5% 79.4% 28.8% 46.9% -8.6% -44.0% -66.0% -88.3% -1.1% -1.1% -1.1% -1.4% 22.8% -1.6% -4.7% -2.0% -1.2% -1.19%
EBITDA 18.8% 4.0% 1.3% 39.3% 4.2% -32.0% -61.1% -77.7% 16.8% 54.9% 1.6% 2.8% -1.2% -1.3% -1.4% -1.2% 6.2% 47.1% 47.06%
Op. Income 16.6% 4.1% 1.4% 42.8% 4.2% -34.7% -66.8% -86.2% -1.1% -1.1% -1.2% -3.4% -6.4% -4.0% -5.3% 81.4% 97.1% 1.2% 1.17%
OCF Growth snapshot only -7.04%
Asset Growth snapshot only -23.57%
Equity Growth snapshot only -34.71%
Debt Growth snapshot only -90.55%
Shares Change snapshot only 2.09%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 43.2% 3.6% -15.7% -25.5% -31.3% -35.4% -38.3% -40.4% -40.5% -34.2% -34.17%
Revenue 5Y 13.6% -3.7% -3.65%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y 1.9% 73.7% 33.2% 5.8%
EBITDA 5Y
Gross Profit 3Y 23.2% -14.3% -29.5% -38.2% -45.2% -50.5% -56.6% -62.3% -64.0% -52.5% -52.53%
Gross Profit 5Y -14.9% -20.9% -20.91%
Op. Income 3Y -52.1% -52.13%
Op. Income 5Y -18.2% -18.18%
FCF 3Y -4.9%
FCF 5Y
OCF 3Y 16.7% -34.8% -52.2% -57.5% -72.7% -76.3%
OCF 5Y
Assets 3Y 5.4% 5.4% 5.4% 5.4% -19.3% -19.3% -19.3% -19.3% -30.4% -30.4% -30.37%
Assets 5Y -9.5% -9.5% -9.52%
Equity 3Y 67.6% 67.6% 67.6% 67.6% 1.0% 1.0% 1.0% 1.0% -27.0% -27.0% -26.97%
Book Value 3Y 59.7% 51.0% 57.3% 59.5% -3.5% -4.3% -4.5% -2.1% -29.3% -29.5% -29.50%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.83 0.49 0.03 0.26 0.05 0.00 0.20 0.60 0.75 0.91 0.92 0.85 0.01 0.08 0.081
Earnings Stability 0.88 0.38 0.00 0.29 0.09 0.23 0.47 0.71 0.34 0.49 0.69 0.69 0.44 0.51 0.509
Margin Stability 0.96 0.96 0.90 0.83 0.78 0.75 0.76 0.74 0.67 0.62 0.58 0.51 0.51 0.57 0.567
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.92 0.87 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.96 0.86 0.857
Earnings Smoothness 0.00 0.00 0.03 0.48 0.81 0.62 0.00 0.00
ROE Trend 0.04 -0.28 -0.74 -1.12 -0.78 -0.81 -0.78 -0.94 -0.50 -0.48 -0.51 -0.13 -0.25 -0.09 -0.085
Gross Margin Trend 0.02 -0.03 -0.13 -0.22 -0.33 -0.36 -0.30 -0.25 -0.23 -0.23 -0.29 -0.32 -0.27 -0.12 -0.117
FCF Margin Trend 0.01 0.13 -0.05 -0.15 -0.30 -0.68 -0.57 -0.50 -0.49 -0.35 -0.42 -0.52 -0.44 -0.15 -0.148
Sustainable Growth Rate 96.5% 1.6% 89.9% 1.1% 1.2% 1.2% 51.2% 35.6% 17.5% 5.7%
Internal Growth Rate 7.2% 12.3% 12.9% 16.5% 18.4% 17.5% 11.7% 7.9% 3.7% 1.2%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 3.32 2.79 2.03 2.18 1.98 2.08 2.43 2.99 4.15 8.87 -1.06 -0.25 -0.23 -0.13 -0.05 -0.04 0.11 0.41 0.44 0.38 0.378
FCF/OCF 0.94 0.95 0.96 0.97 0.98 0.97 0.97 0.95 0.85 0.75 0.48 -0.94 -0.55 -0.39 -3.11 -3.62 2.11 1.34 1.23 1.31 1.313
FCF/Net Income snapshot only 0.496
CapEx/Revenue 3.6% 2.7% 1.9% 1.6% 1.2% 1.8% 1.9% 3.1% 8.4% 13.1% 22.7% 23.1% 17.2% 15.0% 11.8% 12.5% 10.9% 8.8% 7.1% 6.0% 6.03%
CapEx/Depreciation snapshot only 0.210
Accruals Ratio -0.16 -0.20 -0.12 -0.17 -0.15 -0.16 -0.15 -0.15 -0.11 -0.09 -0.13 -0.09 -0.09 -0.14 -0.12 -0.14 -0.14 -0.06 -0.08 -0.07 -0.073
Sloan Accruals snapshot only -0.202
Cash Flow Adequacy snapshot only -3.200
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.4% 1.4%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.2% 0.1% 0.3% 0.2% 0.2% 0.1% 0.0% 0.0% 0.03%
Net Buyback Yield -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.3% -1.3% -1.2% -1.0% -1.0% 0.0% 0.02%
Total Shareholder Return -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.3% -1.3% -1.2% -1.0% -1.0% 0.0% 0.02%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.34 0.35 0.34 0.37 0.39 0.40 0.40 0.40 0.39 0.43 -0.19 -0.22 -0.22 -0.51 0.55 0.56 0.56 0.55 0.56 0.55 0.554
Interest Burden (EBT/EBIT) 0.91 0.93 0.95 0.96 0.97 0.98 0.96 0.93 0.86 0.59 0.93 0.93 0.92 0.89 1.22 1.18 1.12 1.17 1.13 1.18 1.183
EBIT Margin 0.59 0.65 0.70 0.70 0.71 0.68 0.65 0.57 0.41 0.23 2.30 2.35 2.32 1.78 -0.82 -1.03 -1.44 -0.97 -1.12 -0.78 -0.780
Asset Turnover 0.37 0.53 0.50 0.56 0.58 0.57 0.42 0.34 0.26 0.20 0.15 0.15 0.15 0.15 0.21 0.19 0.17 0.15 0.21 0.23 0.230
Equity Multiplier 14.36 14.36 7.89 7.89 7.89 7.89 4.88 4.88 4.88 4.88 3.92 3.92 3.92 3.92 3.36 3.36 3.36 3.36 3.31 3.31 3.308
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.76 $1.14 $1.49 $1.85 $2.03 $1.81 $1.67 $1.16 $0.57 $0.19 $-0.90 $-0.99 $-0.97 $-1.59 $-1.04 $-1.13 $-1.35 $-0.84 $-0.90 $-0.71 $-0.71
Book Value/Share $0.79 $0.73 $2.59 $2.59 $2.59 $2.40 $4.14 $4.14 $4.13 $4.13 $3.15 $3.15 $3.07 $2.94 $2.33 $2.27 $2.26 $2.25 $1.46 $1.45 $2.52
Tangible Book/Share $-2.79 $-2.57 $0.37 $0.37 $0.37 $0.34 $0.34 $0.34 $0.34 $0.34 $-0.99 $-0.98 $-0.96 $-0.92 $-0.21 $-0.21 $-0.20 $-0.20 $-0.47 $-0.47 $-0.47
Revenue/Share $4.14 $5.49 $6.55 $7.34 $7.55 $6.89 $6.71 $5.45 $4.12 $3.18 $2.19 $2.07 $2.05 $1.96 $1.85 $1.69 $1.50 $1.33 $1.28 $1.40 $1.40
FCF/Share $2.38 $3.04 $2.90 $3.92 $3.93 $3.63 $3.94 $3.31 $2.03 $1.23 $0.46 $-0.23 $-0.12 $-0.08 $-0.17 $-0.17 $-0.31 $-0.46 $-0.49 $-0.35 $-0.35
OCF/Share $2.53 $3.19 $3.02 $4.03 $4.02 $3.76 $4.07 $3.48 $2.38 $1.65 $0.96 $0.25 $0.23 $0.21 $0.05 $0.05 $-0.15 $-0.34 $-0.40 $-0.27 $-0.27
Cash/Share $2.10 $1.94 $4.52 $4.52 $4.52 $4.19 $4.80 $4.80 $4.79 $4.79 $4.35 $4.34 $4.23 $4.06 $2.31 $2.25 $2.24 $2.23 $1.50 $1.48 $1.13
EBITDA/Share $2.64 $3.80 $4.80 $5.42 $5.62 $4.90 $4.63 $3.41 $2.02 $1.09 $5.39 $5.26 $5.16 $3.87 $-1.12 $-1.33 $-1.74 $-0.87 $-1.01 $-0.69 $-0.69
Debt/Share $5.26 $4.84 $4.72 $4.72 $4.72 $4.37 $4.45 $4.44 $4.44 $4.44 $4.62 $4.62 $4.50 $4.32 $2.70 $2.63 $2.61 $2.60 $0.25 $0.24 $0.24
Net Debt/Share $3.16 $2.91 $0.20 $0.20 $0.20 $0.18 $-0.36 $-0.36 $-0.36 $-0.36 $0.27 $0.27 $0.27 $0.25 $0.39 $0.38 $0.38 $0.38 $-1.25 $-1.24 $-1.24
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.617
Altman Z-Prime snapshot only 1.884
Piotroski F-Score 4 4 8 8 8 7 6 4 4 4 3 3 4 3 3 3 1 2 1 3 3
Beneish M-Score -1.63 -2.14 -1.95 -1.78 -2.82 -1.22 -0.34 -1.07 -4.19 -3.79 -3.97 -4.16 -3.43 -3.03 -2.78 -2.44 -2.78 -3.08 -3.085
Ohlson O-Score snapshot only -6.315
Net-Net WC snapshot only $-0.69
EVA snapshot only $32362420.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB-
Credit Score 81.28 83.22 90.83 88.00 88.46 88.67 84.08 75.19 69.91 50.36 83.05 80.63 80.45 75.58 39.61 34.68 33.96 33.93 37.58 37.07 37.073
Credit Grade snapshot only 13
Credit Trend snapshot only 2.393
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 29
Sector Credit Rank snapshot only 28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms